Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca to Use Compumine Software for Compound Selection

NEW YORK (GenomeWeb News) – Data-mining software firm Compumine said last week that it has licensed its Rule Discovery System product to AstraZeneca in Sweden.
 
AstraZeneca will use the technology “to improve compound selection throughout its chemistry domains,” the company said in a statement.
 
Niklas Blomberg, associate director of computational chemistry at AstraZeneca, said in a statement that the software enables his team to predict “important safety and physical-chemical properties of our compounds.”

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more